$OCLT

OceanLigh Acquisition Prices IPO Of 10 Mln Shares At $10.00 Per Share

OceanLight Acquisition Corp. priced its IPO at $10.00 per unit, selling 10 million units. Each unit includes one ordinary share, a right to receive one-fourth of an ordinary share at the initial business combination, and a redeemable warrant. Shares and warrants will trade on Nasdaq as OCLT, OCLTR and OCLTW, with units as OCLTU. IPO expected to close Aug. 10, 2026.

Original reporting
Published Aug 7, 2026, 2:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 2:13 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
OceanLigh Acquisition Prices IPO Of 10 Mln Shares At $10.00 Per Share — source image
Decision brief

The 30-second read

$OCLTNeutralMed
01

Why it matters

The key tradable development is the start of unit trading on Nasdaq under OCLTU, followed by separate trading of ordinary shares, rights, and warrants under OCLT, OCLTR, and OCLTW. The warrant strike is $11.50, which is central for warrant valuation once OCLTW trades separately.

02

Market read

This is a primary IPO mechanics update with specific Nasdaq tickers and start timing, enabling event-driven positioning in units and warrants.

03

What to watch

Traders may need to monitor the exact date of separate trading, warrant redemption/adjustment mechanics, and any underwriter over-allotment exercise that could change float and liquidity.

Relevance 7/10Novelty 8/10Timing: begins trading today, Aug 7, 2026 (OCLTU) and separate trading expected thereafter

Background

OceanLight Acquisition Corp. is a Cayman Islands incorporated blank check company pricing an IPO of units.

Company-level read

Ticker impact

$OCLTNeutralLow confidence
Context

After separate trading begins, OceanLight’s ordinary shares are expected to trade on Nasdaq under OCLT.

Expected impact

Moderate volatility around the separate-trading transition date.

Evidence & confidence

The article states the expected ticker but not the specific date or any additional fundamentals beyond the unit structure.

Market effects

Adds a new SPAC-style blank check IPO instrument to the market, which can marginally affect near-term IPO/blank-check supply-demand dynamics.

Primarily US Nasdaq trading activity for the new listings.

Low, as the disclosure is specific to a single newly priced IPO.

Counterpoint

Without information on investor demand, deal structure beyond standard unit components, or any sponsor terms, the trading edge may be limited to mechanical listing effects.

Key entities

  • OceanLight Acquisition Corp.

    Blank check company pricing an IPO of 10 million units at $10.00 per unit.

  • Nasdaq Global Market

    Exchange where the units and subsequent separate securities are expected to trade.

  • Polaris Advisory Partners LLC

    Sole book-running manager for the offering.

Related articles

MedAI 8/10

OceanLight Acquisition prices $100M IPO on Nasdaq

OceanLight Acquisition Corporation priced its Nasdaq IPO at $10.00 per unit, selling 10,000,000 units to raise $100 million, according to a press release. Each unit includes one ordinary share, one right to receive one-fourth share after a business combination, and a redeemable warrant. Units trade as OCLTU; shares and warrants will trade under OCLT, OCLTR, and OCLTW. IPO close expected Aug. 10, 2026.

$HOODMed

Robinhood’s new venture fund comes with a bold risk label

Robinhood is launching Robinhood Ventures Fund II (ticker RVII), a business development company offering 8 million shares at $25 each starting Aug. 13. The fund plans to raise $200 million, led by Goldman Sachs. It invests in Y Combinator-linked seed startups and charges a 2% management fee plus a 20% incentive fee, with estimated annual expenses of 4.18%. The prospectus labels the offering speculative and warns of potential discounts to net asset value.

$BRVEMedAI 8/10

Braveheart Bio closes $439.9 million IPO on Nasdaq

Braveheart Bio, Inc. (NASDAQ:BRVE) completed its IPO, selling 24,437,500 shares at $18.00 each, according to a company press release. The offering raised $439.9 million in gross proceeds, including full exercise of an option for 3,187,500 extra shares. Shares began trading on the Nasdaq Global Market under BRVE.